Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Management of carbapenem-resistant Enterobacteriaceae infections.

Durante-Mangoni E, Andini R, Zampino R.

Clin Microbiol Infect. 2019 Aug;25(8):943-950. doi: 10.1016/j.cmi.2019.04.013. Epub 2019 Apr 18. Review.

PMID:
31004767
2.

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.

Dickstein Y, Lellouche J, Ben Dalak Amar M, Schwartz D, Nutman A, Daitch V, Yahav D, Leibovici L, Skiada A, Antoniadou A, Daikos GL, Andini R, Zampino R, Durante-Mangoni E, Mouton JW, Friberg LE, Dishon Benattar Y, Bitterman R, Neuberger A, Carmeli Y, Paul M; AIDA Study Group .

Clin Infect Dis. 2019 Aug 16;69(5):769-776. doi: 10.1093/cid/ciy988.

PMID:
30462182
3.

The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.

Zak-Doron Y, Dishon Benattar Y, Pfeffer I, Daikos GL, Skiada A, Antoniadou A, Durante-Mangoni E, Andini R, Cavezza G, Leibovici L, Yahav D, Eliakim-Raz N, Carmeli Y, Nutman A, Paul M; AIDA Study Group.

Clin Infect Dis. 2018 Nov 28;67(12):1815-1823. doi: 10.1093/cid/ciy371.

PMID:
29718143
4.

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.

Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L.

Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16.

PMID:
29456043
5.

Direct antiviral treatment of chronic hepatitis C in heart transplant recipients.

Vitrone M, Andini R, Mattucci I, Maiello C, Atripaldi L, Durante-Mangoni E, Zampino R.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12813. Epub 2017 Dec 21.

PMID:
29139181
6.

Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact.

Vitrone M, Iossa D, Rinaldi L, Pafundi PC, Molaro R, Parrella A, Andini R, Ragone E, Maiello C, Zampino R, Durante-Mangoni E.

J Clin Virol. 2017 Nov;96:54-59. doi: 10.1016/j.jcv.2017.09.011. Epub 2017 Sep 23.

PMID:
28964958
7.

Clinical significance of hyperhomocysteinemia in infective endocarditis: A case-control study.

Iossa D, Molaro R, Andini R, Parrella A, Ursi MP, Mattucci I, De Vincentiis L, Dialetto G, Utili R, Durante-Mangoni E.

Medicine (Baltimore). 2016 Sep;95(39):e4972. doi: 10.1097/MD.0000000000004972.

8.

Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.

Durante-Mangoni E, Andini R, Signoriello S, Cavezza G, Murino P, Buono S, De Cristofaro M, Taglialatela C, Bassetti M, Malacarne P, Petrosillo N, Corcione A, Viscoli C, Utili R, Gallo C.

Clin Microbiol Infect. 2016 Dec;22(12):984-989. doi: 10.1016/j.cmi.2016.08.004. Epub 2016 Aug 18.

9.

Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis.

Durante-Mangoni E, Andini R, Parrella A, Mattucci I, Cavezza G, Senese A, Trojaniello C, Caprioli R, Diana MV, Utili R.

Int J Antimicrob Agents. 2016 Jul;48(1):61-68. doi: 10.1016/j.ijantimicag.2016.04.022. Epub 2016 May 25.

PMID:
27259674
10.

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.

Dickstein Y, Leibovici L, Yahav D, Eliakim-Raz N, Daikos GL, Skiada A, Antoniadou A, Carmeli Y, Nutman A, Levi I, Adler A, Durante-Mangoni E, Andini R, Cavezza G, Mouton JW, Wijma RA, Theuretzbacher U, Friberg LE, Kristoffersson AN, Zusman O, Koppel F, Dishon Benattar Y, Altunin S, Paul M; AIDA consortium.

BMJ Open. 2016 Apr 20;6(4):e009956. doi: 10.1136/bmjopen-2015-009956.

11.

Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients.

Durante-Mangoni E, Vitrone M, Parrella A, Andini R, Iossa D, Ragone E, Falco E, Maiello C, Utili R, Zampino R.

Transpl Infect Dis. 2016 Jun;18(3):319-25. doi: 10.1111/tid.12525. Epub 2016 May 10.

PMID:
26988401
12.

Effect of the immunosuppressive regimen on the incidence of cytomegalovirus infection in 378 heart transplant recipients: A single centre, prospective cohort study.

Durante-Mangoni E, Andini R, Pinto D, Iossa D, Molaro R, Agrusta F, Casillo R, Grimaldi M, Utili R.

J Clin Virol. 2015 Jul;68:37-42. doi: 10.1016/j.jcv.2015.04.017. Epub 2015 Apr 22.

PMID:
26071333
13.

Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.

Durante-Mangoni E, Del Franco M, Andini R, Bernardo M, Giannouli M, Zarrilli R.

Diagn Microbiol Infect Dis. 2015 Jul;82(3):222-6. doi: 10.1016/j.diagmicrobio.2015.03.013. Epub 2015 Mar 25.

PMID:
25858028
14.

Recipient-born bloodstream infection due to extensively drug-resistant Acinetobacter baumannii after emergency heart transplant: report of a case and review of the literature.

Andini R, Agrusta F, Mattucci I, Malgeri U, Cavezza G, Utili R, Durante-Mangoni E.

Infection. 2015 Oct;43(5):609-13. doi: 10.1007/s15010-015-0772-z. Epub 2015 Apr 1. Review.

PMID:
25828937
15.

Prevalence and significance of two major inherited thrombophilias in infective endocarditis.

Durante-Mangoni E, Iossa D, Molaro R, Andini R, Mattucci I, Malgeri U, Albisinni R, Utili R.

Intern Emerg Med. 2015 Aug;10(5):587-94. doi: 10.1007/s11739-015-1214-8. Epub 2015 Feb 25.

PMID:
25711313
16.

Differential antiviral effects of pegylated interferon-α2a and pegylated interferon-α2b in chronic hepatitis C.

Durante-Mangoni E, Parrella A, Iossa D, Andini R, Molaro R, Battimelli C, Sodano G, Utili R.

Clin Drug Investig. 2014 Dec;34(12):871-8. doi: 10.1007/s40261-014-0241-y.

PMID:
25349040
17.

Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?

Edwards B, Andini R, Esposito S, Grossi P, Lew D, Mazzei T, Novelli A, Soriano A, Gould IM.

J Glob Antimicrob Resist. 2014 Sep;2(3):133-140. doi: 10.1016/j.jgar.2014.03.009. Epub 2014 May 29. Review.

PMID:
27873719
18.

Infective endocarditis due to multidrug resistant gram-negative bacilli: single centre experience over 5 years.

Durante-Mangoni E, Andini R, Agrusta F, Iossa D, Mattucci I, Bernardo M, Utili R.

Eur J Intern Med. 2014 Sep;25(7):657-61. doi: 10.1016/j.ejim.2014.05.015. Epub 2014 Jun 19.

PMID:
24954705
19.

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.

Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P, Bassetti M, Malacarne P, Petrosillo N, Galdieri N, Mocavero P, Corcione A, Viscoli C, Zarrilli R, Gallo C, Utili R.

Clin Infect Dis. 2013 Aug;57(3):349-58. doi: 10.1093/cid/cit253. Epub 2013 Apr 24.

PMID:
23616495

Supplemental Content

Loading ...
Support Center